Request Sample Inquiry
Generic Drugs Market

Generic Drugs Market

Generic Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

245

Base Year:

2022

Date

Dec - 2024

Format:

PDF XLS PPT

Report Code:

VMR-1660

Segments Covered
  • By Brand By Brand Pure Generic Drugs, Branded Generic Drugs
  • By Route of Drug Administration By Route of Drug Administration Oral, Topical, Parental, Others
  • By Therapeutic Application By Therapeutic Application Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory, Others
  • By Distribution Channel By Distribution Channel Hospitals Pharmacies, Retail Pharmacies, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 411.99 Billion
Revenue 2030Revenue 2030: USD 613.34 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 5.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Generic Drugs Market - Segment Analysis
    1. Overview
    2. Global Generic Drugs Market, 2016 - 2028 (USD Million)
    3. Global Generic Drugs Market - by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. Global Generic Drugs Market - by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. Global Generic Drugs Market - by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. Global Generic Drugs Market - by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. Global Generic Drugs Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Generic Drugs Market - Segment Analysis
    1. Overview
    2. North America Generic Drugs Market, 2016 - 2028 (USD Million)
    3. North America Generic Drugs Market, by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. North America Generic Drugs Market, by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. North America Generic Drugs Market, by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. North America Generic Drugs Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. North America Generic Drugs Market, by Country
      1. U.S.
        1. U.S. Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. U.S. Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. U.S. Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. U.S. Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      2. Canada
        1. Canada Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Canada Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Canada Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Canada Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      3. Mexico
        1. Mexico Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Mexico Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Mexico Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Mexico Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
  5. Europe Generic Drugs Market - Segment Analysis
    1. Overview
    2. Europe Generic Drugs Market, 2016 - 2028 (USD Million)
    3. Europe Generic Drugs Market, by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. Europe Generic Drugs Market, by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. Europe Generic Drugs Market, by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. Europe Generic Drugs Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. Europe Generic Drugs Market, by Country
      1. Germany
        1. Germany Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Germany Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Germany Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Germany Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      2. UK
        1. UK Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. UK Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. UK Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. UK Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      3. France
        1. France Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. France Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. France Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. France Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      4. Spain
        1. Spain Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Spain Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Spain Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Spain Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      5. Italy
        1. Italy Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Italy Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Italy Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Italy Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      6. BENELUX
        1. BENELUX Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. BENELUX Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. BENELUX Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. BENELUX Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      7. Rest of Europe
        1. Rest Of Europe Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Rest Of Europe Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Rest Of Europe Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Rest Of Europe Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
  6. Asia Pacific Generic Drugs Market - Segment Analysis
    1. Overview
    2. Asia Pacific Generic Drugs Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Generic Drugs Market, by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. Asia Pacific Generic Drugs Market, by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. Asia Pacific Generic Drugs Market, by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. Asia Pacific Generic Drugs Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. Asia Pacific Generic Drugs Market, by Country
      1. China
        1. China Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. China Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. China Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. China Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      2. Japan
        1. Japan Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Japan Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Japan Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Japan Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      3. India
        1. India Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. India Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. India Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. India Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      4. South Korea
        1. South Korea Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. South Korea Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. South Korea Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. South Korea Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      5. South East Asia
        1. South East Asia Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. South East Asia Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. South East Asia Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. South East Asia Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Rest of Asia Pacific Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Rest of Asia Pacific Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Rest of Asia Pacific Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
  7. Latin America Generic Drugs Market - Segment Analysis
    1. Overview
    2. Latin America Generic Drugs Market, 2016 - 2028 (USD Million)
    3. Latin America Generic Drugs Market, by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. Latin America Generic Drugs Market, by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. Latin America Generic Drugs Market, by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. Latin America Generic Drugs Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. Latin America Generic Drugs Market, by Country
      1. Brazil
        1. Brazil Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Brazil Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Brazil Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Brazil Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      2. Argentina
        1. Argentina Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Argentina Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Argentina Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Argentina Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      3. Rest of Latin America
        1. Rest of Latin America Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Rest of Latin America Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Rest of Latin America Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Rest of Latin America Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
  8. Middle East & Africa Generic Drugs Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Generic Drugs Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Generic Drugs Market, by Brand
      1. By Pure Generic Drugs
      2. By Branded Generic Drugs
    4. Middle East & Africa Generic Drugs Market, by Route of Drug Administration
      1. By Oral
      2. By Topical
      3. By Parental
      4. By Others
    5. Middle East & Africa Generic Drugs Market, by Therapeutic Application
      1. By Central Nervous System (CNS)
      2. By Cardiovascular
      3. By Dermatology
      4. By Oncology
      5. By Respiratory
      6. By Others
    6. Middle East & Africa Generic Drugs Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Others
    7. Middle East & Africa Generic Drugs Market, by Country
      1. GCC Countries
        1. GCC Countries Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. GCC Countries Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. GCC Countries Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. GCC Countries Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      2. South Africa
        1. South Africa Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. South Africa Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. South Africa Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. South Africa Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Generic Drugs Market, By Brand
          1. By Pure Generic Drugs
          2. By Branded Generic Drugs
        2. Rest of Middle East & Africa Generic Drugs Market, By Route of Drug Administration
          1. By Oral
          2. By Topical
          3. By Parental
          4. By Others
        3. Rest of Middle East & Africa Generic Drugs Market, By Therapeutic Application
          1. By Central Nervous System (CNS)
          2. By Cardiovascular
          3. By Dermatology
          4. By Oncology
          5. By Respiratory
          6. By Others
        4. Rest of Middle East & Africa Generic Drugs Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Mylan N.V.
    2. Abbott Laboratories
    3. ALLERGAN
    4. Teva Pharmaceutical Industries Ltd.
    5. Eli Lilly and Company
    6. STADA Arzneimittel AG
    7. GlaxoSmithKline PLC.
    8. Baxter International Inc.
    9. Pfizer Inc.
    10. Sandoz International GmbH
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Generic Drugs valued at USD 411.99 Billion in 2022 and is expected to reach USD 613.34 Billion in 2030 growing at a CAGR of 5.10%.

  • The prominent players in the market are Mylan N.V., Abbott Laboratories, ALLERGAN, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, STADA Arzneimittel AG, GlaxoSmithKline PLC., Baxter International Inc., Pfizer Inc., Sandoz International GmbH.

  • The market is project to grow at a CAGR of 5.10% between 2023 and 2030.

  • The driving factors of the Generic Drugs include

    • Rising incidence of chronic diseases

  • North America was the leading regional segment of the Generic Drugs in 2022.